I-BEIJING SUCCEEDER TECHNOLOGY INC.

Umbhalo wesine obalulekile wokuvumelana, oholwa yiKomidi le-Thrombosis and Hemostasis le-Chinese Association of Research Hospitals, ukhishwe.

"Isivumelwano Sochwepheshe Sokuqapha Emitholampilo Yezidakamizwa Ezifana Ne-Heparin" sakhiwe ngokubambisana yiKomidi Le-Thrombosis and Hemostasis le-Chinese Association of Research Hospitals kanye neGatsha Lesayensi Yelabhorethri le-Chinese Geriatrics Society. Lo mbhalo, owabhalwa ngokubambisana ngochwepheshe bemikhakha eyahlukahlukene abavela kulo lonke elaseShayina, wathatha iminyaka emibili ukuwuthuthukisa, ngemuva kwezingxoxo eziningi kanye nokubuyekezwa. Uhlaka lokugcina lwavunyelwana ngalo futhi lwashicilelwa ngo-Agasti 2025 kuyi-Chinese Journal of Laboratory Medicine, uMqulu 48, Issue 8.

Lokhu kuvumelana kunikeza isiqondiso esijwayelekile sokuqapha izidakamizwa ezifana ne-heparin elebhu, okunikeza ukwesekwa okuthembekile kakhulu kwelebhu ukuze kusetshenziswe ngokuphephile nangokuphumelelayo ukwelashwa kwe-anticoagulant emitholampilo. Ekugcineni, kuzozuzisa iziguli eziningi futhi kwenze ukwelashwa kwe-heparin anticoagulant kube okujwayelekile nokunembile.

ISIFINYEZO

Imithi efana ne-heparin ivame ukusetshenziswa njengemithi yokulwa nokuvuvukala kwegazi ukuvimbela nokwelapha izifo ze-thromboembolic. Ukusetshenziswa okufanele kanye nokuqapha okufanele kwale mithi kubalulekile ekuqinisekiseni ukuphepha nokusebenza kahle kokwelashwa. Lokhu kuvumelana kochwepheshe kusekelwe ezincwadini ezifanele zasekhaya nezamazwe ngamazwe, kucatshangelwa ngokugcwele isimo samanje kanye nenqubekela phambili yokusetshenziswa kwe-heparin. Yabiza iphaneli yochwepheshe emkhakheni we-antithrombotic, okuhlanganisa nochwepheshe belabhoratri kanye nabezokwelapha, ukuze baxoxe ngezinkomba, umthamo, kanye nokuqapha i-heparin. Ikakhulukazi, yacacisa ukusetshenziswa kwemitholampilo kwezinkomba zelabhoratri ezifana nomsebenzi we-anti-Xa futhi yakha izincomo zochwepheshe ngenhloso yokukhuthaza ukusetshenziswa okuphephile nokusebenzayo kwe-heparin kanye nokwenza ukuqapha kwelabhoratri kube ngokwejwayelekile.Lesi sihloko siphinde sanyatheliswa kusukela ku: Thrombosis and Hemostasis (CSTH).

I-Beijing Succeeder Technology Inc. (ikhodi yesitoko: 688338) ibilokhu ihileleke kakhulu emkhakheni wokuxilongwa kokuqina kwegazi selokhu yasungulwa ngo-2003, futhi izibophezele ekubeni ngumholi kulo mkhakha. Indlunkulu yayo eBeijing, inethimba eliqinile le-R&D, lokukhiqiza kanye nelokuthengisa, eligxile ekusungulweni nasekusetshenzisweni kobuchwepheshe bokuxilonga i-thrombosis kanye ne-hemostasis.

Ngenxa yamandla ayo obuchwepheshe avelele, iSucceeder iwine ama-patents agunyaziwe angu-45, okuhlanganisa ama-patents okusungula angu-14, ama-patents emodeli yokusetshenziswa angu-16 kanye nama-patents okuklama angu-15. Le nkampani futhi inezitifiketi zokubhaliswa komkhiqizo wedivayisi yezokwelapha zesigaba sesi-2 ezingu-32, izitifiketi zokufaka zesigaba sesi-3, kanye nesitifiketi se-EU CE semikhiqizo engu-14, futhi iphumelele isitifiketi sesistimu yokuphatha ikhwalithi ye-ISO 13485 ukuqinisekisa ubuhle nokuzinza kwekhwalithi yomkhiqizo.

I-Succeeder ayiyona nje ibhizinisi elibalulekile le-Beijing Biomedicine Industry Leapfrog Development Project (G20), kodwa futhi yafika ngempumelelo kwi-Science and Technology Innovation Board ngo-2020, yafinyelela intuthuko eqhubekayo yenkampani. Njengamanje, inkampani yakhe inethiwekhi yokuthengisa kazwelonke ehlanganisa amakhulu ama-ejenti namahhovisi. Imikhiqizo yayo ithengiswa kahle ezingxenyeni eziningi zezwe. Iphinde yandise ngenkuthalo izimakethe zaphesheya kwezilwandle futhi ithuthukisa njalo ukuncintisana kwayo kwamazwe ngamazwe.